Alexopoulos, Anastasia-Stefania http://orcid.org/0000-0002-0690-1526
Danus, Susanne
Parish, Alice
Olsen, Maren K.
Batch, Bryan C.
Thacker, Connie R.
Moylan, Cynthia A.
Crowley, Matthew J.
Funding for this research was provided by:
NCATS (KL2TR002554, UL1TR002553)
NIH (1R01NR019594)
Quality Enhancement Research Initiative (VA QUE 20-012)
Article History
Received: 5 August 2024
Accepted: 30 August 2024
First Online: 14 September 2024
Declarations
:
: Cynthia A. Moylan has consulted for NovoNordisk and has served on the advisory board for Boehringer Ingelheim, Inc. Cynthia A. Moylan has also received grants from GlaxoSmithKline, Exact Sciences, and Madrigal to conduct research at Duke University. Anastasia-Stefania Alexopoulos, Susanne Danus, Alice Parish, Maren K. Olsen, Connie R. Thacker, Bryan C. Batch and Matthew J. Crowley have no competing interests for this work.
: This study was approved by the Duke Health Institutional Review Board (protocol number Pro00113239) and was registered on ClinicalTrials.gov (NCT05844137) before study initiation. Written informed consent was obtained from all participants in this study for: (a) participation in the study; and (b) publication of data. This study was performed in accordance with the Helsinki Declaration of 1964, and its later amendments.